Advertisement

Lipidstoffwechsel in normgewichtigen PCOS-Patientinnen

  • Anda‑Petronela RadanEmail author
Noch gewusst…?
  • 6 Downloads

Lipid Metabolism in non-adipose PCOS patients

Notes

Einhaltung ethischer Richtlinien

Interessenkonflikt

A. Radan gibt an, dass kein Interessenkonflikt besteht.

Dieser Beitrag beinhaltet keine von der Autorin durchgeführten Studien an Menschen oder Tieren.

Literatur

  1. 1.
    Moran LJ, Brinkworth G, Noakes M, Norman RJ (2006) Effects of lifestyle modification in polycystic ovarian syndrome. Reprod Biomed Online 12(5):569–578CrossRefGoogle Scholar
  2. 2.
    Australian Government (2018) International evidence-based guideline for the assessment and management of polycystic ovary syndrome 2018. https://www.eshre.eu/Guidelines-and-Legal/Guidelines/Polycystic-Ovary-Syndrome Google Scholar
  3. 3.
    Toosy S, Sodi R, Pappachan JM (2018) Lean polycystic ovary syndrome (PCOS): an evidence-based practical approach. J Diabetes Metab Disord 17(2):277–285.  https://doi.org/10.1007/s40200-018-0371-5 CrossRefPubMedGoogle Scholar
  4. 4.
    Behboudi-Gandevani S, Ramezani Tehrani F, Rostami Dovom M, Farahmand M, Bahri Khomami M, Noroozzadeh M et al (2016) Insulin resistance in obesity and polycystic ovary syndrome: systematic review and meta-analysis of observational studies. Gynecol Endocrinol 32(5):343–353.  https://doi.org/10.3109/09513590.2015.1117069 CrossRefPubMedGoogle Scholar
  5. 5.
    Zhu S, Zhang B, Jiang X, Li Z, Zhao S, Cui L et al (2019) Metabolic disturbances in non-obese women with polycystic ovary syndrome: a systematic review and meta-analysis. Fertil Steril 111(1):168–177.  https://doi.org/10.1016/j.fertnstert.2018.09.013 CrossRefPubMedGoogle Scholar
  6. 6.
    Huang S, Qiao J, Li R, Wang L, Li M (2010) Can serum apolipoprotein C‑I demonstrate metabolic abnormality early in women with polycystic ovary syndrome? Fertil Steril 94:205–210CrossRefGoogle Scholar
  7. 7.
    Dawood AS, Elgergawy A, Elhalwagy A (2018) Circulating levels of vitamin D3 and Leptin in lean infertile women with Polycystic ovary syndrome. J Hum Reprod Sci 11(4):343–347.  https://doi.org/10.4103/jhrs.JHRS_40_18 CrossRefPubMedPubMedCentralGoogle Scholar
  8. 8.
    Wild RA, Carmina E, Diamanti-Kandarakis E, Dokras A, Escobar-Morreale HF, Futterweit W et al (2010) Assessment of cardiovascular risk and prevention of cardiovascular disease in women with the polycystic ovary syndrome. J Clin Endocrinol Metab 95:2038–2049 (A consensus statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society)CrossRefGoogle Scholar
  9. 9.
    Goyal M, Dawood AS (2017) Debates regarding lean patients with Polycystic ovary syndrome: a narrative review. J Hum Reprod Sci 10(3):154–161.  https://doi.org/10.4103/jhrs.JHRS_77_17 CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Springer-Verlag GmbH Austria, ein Teil von Springer Nature 2019

Authors and Affiliations

  1. 1.Universitätsklinik für FrauenheilkundeInselspital BernBernSchweiz

Personalised recommendations